MNCs say developing world diseases also part of their focus
This article was originally published in Scrip
Executive Summary
Multinational pharma companies (MNCs) operating in India have sought to debunk the general perception that they focus on diseases of the Western world and are doing little to improve access to drugs in areas such as rural India, which are characterised by poor access to medication.